Primary liver cancer incidence among American Indians and Alaska Natives, US, 1999-2004

Cancer

Volumn 113, Issue 5 SUPPL., 2008, Pages 1244-1255

  Jim, Melissa A ^a,b,j   Perdue, David G ^c,d   Richardson, Lisa C ^a   Espey, David K ^a,b   Redd, John T ^a,b   Martin, Howard J ^e   Kwong, Sandy L ^f   Kelly, Janet J ^g   Henderson, Jeffrey A ^h   Ahmed, Faruque ⁱ  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b INDIAN HEALTH SERVICE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d Minnesota Gastroenterology   (United States)

^e VIRGINIA DEPARTMENT OF HEALTH   (United States)

^f Cancer Surveillance Section   (United States)

^g Alaska Native Epidemiology Center   (United States)

^h Black Hills Center for American Indian Health   (United States)

ⁱ NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^j Albuquerque Area Indian Health Service   (United States)

more..

Author keywords

Alaska native; American Indian; Health disparity; Hepatocellular carcinoma; Incidence; Liver cancer; Misclassification; NPCR; SEER; United states

Indexed keywords

AGE DISTRIBUTION; AMERICAN INDIAN; ARTICLE; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CONFIDENCE INTERVAL; CORRELATION ANALYSIS; DATA ANALYSIS; ETHNIC DIFFERENCE; HEALTH DISPARITY; LIVER CANCER; LIVER CELL CARCINOMA; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; STATISTICAL ANALYSIS; UNITED STATES; ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; CHILD; ESKIMO; ETHNOLOGY; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; INFANT; LIVER TUMOR; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; RACE; REGISTER; STATISTICS;

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALASKA; CHILD; CHILD, PRESCHOOL; CONTINENTAL POPULATION GROUPS; FEMALE; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INFANT; INFANT, NEWBORN; INUITS; LIVER NEOPLASMS; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; UNITED STATES;

EID: 53449095357     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23728     Document Type: Article

References (75)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557-2576.
2. Fujita Y, Shibata A, Ogimoto I, et al. The effect of interaction between hepatitis C virus and cigarette smoking on the risk of hepatocellular carcinoma. Br J Cancer. 2006;94:737-739.
3. Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 2005;42:218-224.
4. Mohamed AE, Kew MC, Groeneveld HT. Alcohol consumption as a risk factor for hepatocellular carcinoma in urban southern African blacks. Int J Cancer. 1992;51:537-541.
5. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology. 2004;127(5 suppl 1): S87-S96.
6. Tanaka K, Hirohata T, Takeshita S, et al. Hepatitis B virus, cigarette smoking and alcohol consumption in the development of hepatocellular carcinoma: a case-control study in Fukuoka. Jpn Int J Cancer. 1992;51:509-514.
7. Yuan JM, Govindarajan S, Arakawa K, Yu MC. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer. 2004;101:1009-1017.
8. Zhu K, Moriarty C, Caplan LS, Levine RS. Cigarette smoking and primary liver cancer: a population-based case-control study in US men. Cancer Causes Control. 2007;18:315-321.
9. Shaib YH, El-Serag HB, Nooka AK, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol. 2007;102:1016-1021.
10. Welzel TM, Mellemkjaer L, Gloria G, et al. Risk factors for intrahepatic cholangiocarcinoma in a low-risk population: a nationwide case-control study. Int J Cancer. 2007;120:638-641.
11. Lazaridis KN, Gores GJ. Primary sclerosing cholangitis and cholangiocarcinoma. Semin Liver Dis. 2006;26:42-51.
12. Lim MK, Ju YH, Franceschi S, et al. Clonorchis sinensis infection and increasing risk of cholangiocarcinoma in the Republic of Korea. Am J Trop Med Hyg. 2006;75:93-96.
13. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA. Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology. 2005; 128:620-626.
14. Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis. Am J Gastroenterol. 2004;99:523-526.
15. National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Surveillance, Epidemiology, and End Results (SEER) program SEER*Stat database: Incidence-SEER 17 Regs Limited-Use, Nov 2005 Sub (2000-2003) -Linked To County Attributes-Total U.S., 1969-2003 Counties. Released April 2006, based on the November 2005 submission. Available at: http://www.seer.cancer.gov. Accessed on February 26, 2007.
16. Espey D, Wu X-C, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer. 2007;110:2119-2152.
17. Espey D, Paisano R, Cobb N. Regional patterns and trends in cancer mortality among American Indians and Alaska Natives, 1990-2001. Cancer. 2005;103:1045-1053.
18. Vong S, Bell BP. Chronic liver disease mortality in the United States, 1990-1998. Hepatology. 2004;39:476-483.
19. Frost F, Taylor V, Fries E. Racial misclassification of Native Americans in a surveillance, epidemiology, and end results cancer registry. J Natl Cancer Inst. 1992;84:957-962.
20. Rosenberg HM, Maurer JD, Sorlie PD, et al. Quality of death rates by race and Hispanic origin: a summary of current research, 1999. Vital Health Stat 2. September 1999:1-13.
21. Arias E, Schauman WS, Eschback K, Sorlie PD. The validity of race and Hispanic origin reporting on death certificates in the United States. National Center for Health Statistics report 2008 (in press).
22. Swan J, Edwards BK. Cancer rates among American Indians and Alaska Natives: is there a national perspective. Cancer. 2003;98:1262-1272.
23. Puukka E, Stehr-Green P, Becker TM. Measuring the health status gap for American Indians/Alaska Natives: getting closer to the truth. Am J Public Health. 2005;95:838-843.
24. Mettlin CJ, Menck HR, Winchester DP, Murphy GP. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program. Cancer. 1997;79:2052-2061.
25. Ioannou GN, Chapko MK, Dominitz JA. Predictors of colorectal cancer screening participation in the United States. Am J Gastroenterol. 2003;98:2082-2091.
26. Espey DK, Wiggins CL, Becker TM, Jim MA, Johnson CJ, Miller BA. Methods for improving cancer surveillance data in American Indian and Alaska Native populations. Cancer. 2008;113(5 suppl):1120-1130.
27. D'Angelo AJ. American Indians and Alaska Natives: Defining where they reside. The IHS Provider. 1996;21:36-42.
28. US Cancer Statistics Working Group. United States cancer statistics: 2004 incidence and mortality. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, and National Cancer Institute; 2007.
29. Hankey BF, Ries LA, Edwards BK. The surveillance, epidemiology, and end results program: a national resource. Cancer Epidemiol Biomarkers Prev. 1999;8:1117-1121.
30. Thoburn KK, German RR, Lewis M, Nichols PJ, Ahmed F, Jackson-Thompson J. Case completeness and data accuracy in the Centers for Disease Control and Prevention's National Program of Cancer Registries. Cancer. 2007;109:1607-1616.
31. Fritz A, Percy C, Jack A. International classification of diseases of oncology. Geneva, Switzerland: World Health Organization; 2000.
32. Surveillance, Epidemiology, and End Results Program. Summary staging manual 2000. Bethesda, MD: National Institutes of Health, National Cancer Institute; 2005.
33. Gu D. Link Plus: a suite of publicly available software programs for collecting and processing cancer registry data. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention, and Health Promotion, US Department of Health and Human Services; 2005. Available at: http://www.cdc.gov/cancer/npcr/tools/registryplus/lp.htm. Accessed on April 4, 2008.
34. Jim MA, Espey DK, Wiggins C, Cobb N, Wingo PA. Racial misclassification of American Indians residing near IHS facilities. Poster P-47 at: Final Program and Abstracts, North American Association of Central Cancer Registries 2006 Conference; June 10-16, 2006; Regina, Saskatchewan, Canada.
35. Ingram DD, Parker JD, Schenker N, et al. United States Census 2000 population with bridged race categories. Vital Health Stat 2. September 2003:1-55.
36. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. Statistical resources. U.S. population data 1969-2004. Available at: http://seer.cancer.gov/resources. Accessed on December 13, 2006.
37. Goodman MT, Howe HL. Descriptive epidemiology of ovarian cancer in the United States, 1992-1997. Cancer. 2003; 97(10 suppl):2615-2630.
38. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res. 2006;15:547-569.
39. Surveillance Research Program. National Cancer Institute SEER*Stat software, version 6.3.6. Available at: http://www.seer.cancer.gov/seerstat. Accessed on April 16, 2007.
40. Ahmed F, Perz JF, Kwong S, Jamison PM, Friedman C, Bell BP. National trends and disparities in the incidence of hepatocellular carcinoma, 1998-2003. Prev Chronic Dis. 2008;5:A74.
41. Paltoo DN, Chu KC. Patterns in cancer incidence among American Indians/Alaska Natives, United States, 1992-1999. Public Health Rep. 2004;119:443-451.
42. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology. 2004;127(5 suppl 1):S27-S34.
43. National Institutes of Health Consensus Development Conference Panel. Management of hepatitis C. Hepatology. 1997; 26(3 suppl 1):2S-10S.
44. Strader DB, Wright T, Thomas DL, Seeff LB. Diagnosis, management, and treatment of hepatitisC. Hepatology. 2004;39:1147-1171.
45. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
46. Niederau C, Lange S, Heintges T, et al. Prognosis of chronic hepatitis C: results of a large, prospective cohort study. Hepatology. 1998;28:1687-1695.
47. Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitisC. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet. 1997;349:825-832.
48. Rawls RA, Vega KJ. Viral hepatitis in minority America. J Clin Gastroenterol. 2005;39:144-151.
49. Davis GL, Albright JE, Cook SF, Rosenberg DM. Projecting future complications of chronic hepatitis C in the United States. Liver Transpl. 2003;9:331-338.
50. Wong JB, McQuillan GM, McHutchison JG, Poynard T. Estimating future hepatitis C morbidity, mortality, and costs in the United States. Am J Public Health. 2000;90:1562-1569.
51. Castor ML, Smyser MS, Taualii MM, Park AN, Lawson SA, Forquera RA. A nationwide population-based study identifying health disparities between American Indians/Alaska Natives and the general populations living in select urban counties. Am J Public Health. 2006;96:1478-1484.
52. Fattovich G, Stroffolini T, Zagni I, Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology. 2004;127(5 suppl 1):S35-S50.
53. Shore JH, Beals J, Orton H, Buchwald D. Comorbidity of alcohol abuse and dependence with medical conditions in 2 American Indian reservation communities. Alcohol Clin Exp Res. 2006;30:649-655.
54. Bialek SR, Redd JT, Lynch A, et al. Chronic liver disease among 2 American Indian patient populations in the southwestern United States, 2000-2003. J Clin Gastroenterol. 2008 (in press).
55. Centers for Disease Control and Prevention. Behavioral risk factor surveillance system survey questionnaire. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2007.
56. Steele CB, Cardinez CJ, Richardson LC, Tom-Orme L, Shaw K. Surveillance for health behaviors of American Indians and Alaska Natives - findings from the Behavioral Risk Factor Surveillance System, 2000-2006. Cancer. 2008; 113(5 suppl):1131-1141.
57. Poynard T, Ratziu V, Benmanov Y, Di Martino V, Bedossa P, Opolon P. Fibrosis in patients with chronic hepatitis C: detection and significance. Semin Liver Dis. 2000;20:47-55.
58. El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol. 2002;35(5 suppl 2):S72-S78.
59. Yoshida EM, Riley M, Arbour LT. Autoimmune liver disease and the Canadian First Nations aboriginal communities of British Columbia's Pacific Northwest. World J Gastroenterol. 2006;12:3625-3627.
60. Arbour L, Field L, Ross P, Erikson A, Yoshida E. The mystery of primary biliary cirrhosis in British Columbia's First Nations people. Int J Circumpolar Health. 2004;63(suppl 2): 185-188.
61. Hurlburt KJ, McMahon BJ, Deubner H, Hsu-Trawinski B, Williams JL, Kowdley KV. Prevalence of autoimmune liver disease in Alaska Natives. Am J Gastroenterol. 2002;97: 2402-2407.
62. McMahon BJ, Hennessy TW, Christensen C, et al. Epidemiology and risk factors for hepatitis C in Alaska Natives. Hepatology. 2004;39:325-332.
63. McMahon BJ, Rhoades ER, Heyward WL, et al. A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan Natives. Lancet. 1987;2:1134-1136.
64. McMahon BJ, Schoenberg S, Bulkow L, et al. Seroprevalence of hepatitis B viral markers in 52,000 Alaska Natives. Am J Epidemiol. 1993;138:544-549.
65. Schreeder MT, Bender TR, McMahon BJ, et al. Prevalence of hepatitis B in selected Alaskan Eskimo villages. Am J Epidemiol. 1983;118:543-549.
66. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4:369-380.
67. Richardson LC, Pollack LA. Therapy Insight: influence of type II diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol. 2005;2:48-53.
68. Bugianesi E. Review article: steatosis, the metabolic syndrome and cancer. Aliment Pharmacol Ther. 2005;22(suppl 2):40-43.
69. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch Intern Med. 2000;160:3227-3230.
70. Denny CH, Holtzman D, Cobb N. Surveillance for health behaviors of American Indians and Alaska Natives. Findings from the Behavioral Risk Factor Surveillance System, 1997-2000. MMWR Surveill Summ. 2003;52:1-13.
71. Acton KJ, Burrows NR, Moore K, Querec L, Geiss LS, Engelgau MM. Trends in diabetes prevalence among American Indian and Alaska Native children, adolescents, and young adults. Am J Public Health. 2002;92:1485-1490.
72. World Health Organization/International Agency for Research on Cancer. Tobacco smoke and involuntary smoking: summary of data reported and evaluation. IARC Monogr Eval Carcinog Risks Hum. 2002;83:1-12.
73. Denny CH, Taylor TL. American Indian and Alaska Native health behavior: findings from the behavioral risk factor surveillance system, 1992-1995. Ethn Dis. 1999;9:403-409.
74. Rugge JB, Lochner J, Judkins D. What is the best surveillance for hepatocellular carcinoma in chronic carriers of hepatitis B? J Fam Pract 2006;55:155-156; discussion 155.
75. McMahon BJ, Bulkow L, Harpster A, et al. Screening for hepatocellular carcinoma in Alaska Natives infected with chronic hepatitis B: a 16-year population-based study. Hepatology. 2000;32(4 pt 1):842-846.